INCIDENCE OF BIOFILM FORMATION IN VARIOUS CANDIDA SPECIES ISOLATED FROM CLINICAL SAMPLES AT GOVERNMENT MEDICAL COLLEGE, KOTA.
Main Article Content
Keywords
Candida species, biofilm, Infection, fungi
Abstract
Candida species are typical skin and mucosal dwellers. Given the rise in these infections during the past ten years, the significance of epidemiological monitoring of yeasts implicated in pathogenic processes is undeniable. Clinical samples were obtained and cultured from the respiratory tract (sputum, bronchial wash, tracheal secretions), saliva, blood, urine, middle ear discharge, vitreous fluid, corneal ulcer, and plastic devices (endotracheal tube, catheter tip, suction tip). The isolated species of Candida were identified. From 270 different clinical sources, 100 isolates of Candida species were found. The most isolated species was Candida albicans (39.5 %), however the most common species was Candida non-albicans (60.5%). C. albicans (20.58%) and C. krusei (38.23%) were commonly isolated in blood cultures. The most common species on the mucosal surface was Candida albicans (63.27%). Hospitalized patients were more likely to have urinary tract infections brought on by yeasts, with C. krusei (50.0%) and C. albicans (25.0%) being the most often isolated. The pathogenecity is influenced by a number of virulence factors, including biofilm, proteinase, phospholipase, etc. Clinical decision-making benefits from early discovery of Candida virulence factors. Therefore, our goal has been to show how biofilm forms using the technique suggested by Branchini et al. (1994). The Staib et al. (1965) approach was used to determine the amount of proteinase generated by Candida. The phospholipase assay was performed using the Samaranayake et al. (2005) method. Conclusions: The findings points to the possibility that the pathogenic potential of the isolates may be reflected in the ability of Candida species to form biofilm. Strong slime production was demonstrated by C. tropicalis and C. krusei. Compared to Candida albicans, the non-Candida albicans produced more proteinase. In this investigation, Candida albicans produced more phospholipase than non-Candida albicans.
References
2. Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Adherence and biofilm formation of non-Candida albicans Candida species. Trends Microbiol. 2011 May;19(5):241-7. doi: 10.1016/j.tim.2011.02.003. Epub 2011 Mar 15. PMID: 21411325.Cutler JE. Putative virulence factors of Candida albicans. Annu Rev Microbiol 1991;45:187-218.
3. Pfaller MA, Messer SA, Hollis RJ. Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis. Diagn Microbiol Infect Dis. 1995 Jan;21(1):9-14. doi: 10.1016/0732-8893(94)00114-c. PMID: 7789100.Staib F. Serum-proteins as nitrogen source for yeast like fungi. Sabouraudia 1965;4:187-93.
4. Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA. Differential expression of Candida albicans phospholipase B (PLB1) under various environmental and physiological conditions. Microbiology (Reading). 2003 Jan;149(Pt 1):261-7. doi: 10.1099/mic.0.25829-0. PMID: 12576599.Chakrabarti A, Singh K, Das S. Changing face of nosocomial candidaemia. Indian J Med Microbiol 1999;17:160-6.
5. D’Antonio D, Romani F, Pontieri E, Carruba G. Catheter related candidaemia caused by Candida lipolytica in a patient receiving allogenic bone marrow transplantation; J Clin Microbiol 2002;40:1381-6.
6. Pfaller MA, Messer SA, Hollis RJ. Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis. Diagn Microbiol Infect Dis. 1995 Jan;21(1):9-14. doi: 10.1016/0732-8893(94)00114-c. PMID: 7789100.Vinitha M, Ballal M. Proteinase and phospholipase as virulence factors in Candida isolated from blood. Rev Iberoam Micol 2008;25:208-10.
7. Hendry AT, Bakerspigel A. Factors affecting serum inhibited growth of Candida albicans and Cryptococcus neoformans. Sabouraudia. 1969 Oct;7(3):219-29. PMID: 5385158. Yücesoy M, Karaman M. Candida türlerinin biyofilm üretimi ve antifungal duyarlilik paternleri [Biofilm production and antifungal susceptibility patterns of Candida species]. Mikrobiyol Bul. 2004 Jan-Apr;38(1-2):91-8. Turkish. PMID: 15293907. inhibitory concentration values of antifungal agents. Mem Inst Oswaldo Cruz 2005;100:319-24.
8. Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA. Differential expression of Candida albicans phospholipase B (PLB1) under various environmental and physiological conditions. Microbiology (Reading). 2003 Jan;149(Pt 1):261-7. doi: 10.1099/mic.0.25829-0. PMID: 12576599.
9. Chakrabarti A, Singh K, Das S. Changing face of nosocomial candidaemia. Indian J Med Microbiol 1999;17:160-6.
10. Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun. 2002 Feb;70(2):878-88. doi: 10.1128/IAI.70.2.878-888.2002. PMID: 11796623; PMCID: PMC127692.
11. Astiz ME, Rackow EC, Still JG. et al. Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: A prospective, double-blind, randomized, controlled trial. Crit Care Med. 1995;23:9. [PubMed]
12. Mattei AS, Alves SH, Severo CB, Guazzelli Lda S, Oliveira Fde M, Severo LC. Determination of germ tube, phospholipase, and proteinase production by bloodstream isolates of Candida albicans. Rev Soc Bras Med Trop. 2013 May-Jun;46(3):340-2. doi: 10.1590/0037-8682-0045-2013. PMID: 23856861.
13. Riceto ÉB, Menezes Rde P, Penatti MP, Pedroso Rdos S. Enzymatic and hemolytic activity in different Candida species. Rev Iberoam Micol. 2015 Apr-Jun;32(2):79-82. doi: 10.1016/j.riam.2013.11.003. Epub 2014 Apr 1. PMID: 24704439.
14. Arendrup MC. Candida and candidaemia. Susceptibility and epidemiology. Dan Med J. 2013 Nov;60(11):B4698. PMID: 24192246.
15. Chandra J, Mukherjee PK, Ghannoum MA. In vitro growth and analysis of Candida biofilms. Nat Protoc. 2008;3(12):1909-24. doi: 10.1038/nprot.2008.192. PMID: 19180075.
16. Yücesoy M, Karaman M. Candida türlerinin biyofilm üretimi ve antifungal duyarlilik paternleri [Biofilm production and antifungal susceptibility patterns of Candida species]. Mikrobiyol Bul. 2004 Jan-Apr;38(1-2):91-8. Turkish. PMID: 15293907.
17. K. Hooli, S. Thilakawardana, J. Lara, J-P. Kermoal,S. Pfletschinger, "Flexible Spectrum Use betweenWINNER Radio Access networks", IST Mobile Summit, Greece, June 2006.
18. Mattei AS, Alves SH, Severo CB, Guazzelli Lda S, Oliveira Fde M, Severo LC. Determination of germ tube, phospholipase, and proteinase production by bloodstream isolates of Candida albicans. Rev Soc Bras Med Trop. 2013 May-Jun;46(3):340-2. doi: 10.1590/0037-8682-0045-2013. PMID: 23856861.

